SPOT-MAS is a non-invasive, multi-cancer early detection (MCED) test that detects tumor DNA (ctDNA) circulating in the blood. This test incorporates next-generation sequencing (NGS) and AI technologies to analyze the multiple features of ctDNA, enabling early detection for the 10 most common and aggressive cancers(*) from a single tube of blood.
Cancer:
Biliary Tract Cancer, Breast Cancer, Colorectal Cancer, Esophageal Cancer, Liver Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer